x.com· @ · X·· 2026-04-22Score60
Reading
KRAS / RAS targeting: from platform to Phase 3
daraxonrasib ± GnP · mono ORR 47%; +GnP ORR 55%, DCR 90%
Body
Back home from #AACR26 on the red eye from San Diego. This meeting really felt like we were turning the tide on #PancreaticCancer. If you missed the session, you can watch it (and all others) on the @AACR virtual platform.
Thanks @Carolynyjohnson
https://t.co/8fGiGHWr4c https://t.co/u8iiW8FOTa
Heat 179 · 147 likes · 4 replies · 28 reposts
Source: x.com · x.com